Fortis Malar Hospitals Past Earnings Performance
We're still processing the latest earnings report of this company
Past criteria checks 3/6
Fortis Malar Hospitals has been growing earnings at an average annual rate of 29.2%, while the Healthcare industry saw earnings growing at 28% annually. Revenues have been declining at an average rate of 13.1% per year. Fortis Malar Hospitals's return on equity is 44%, and it has net margins of 116.8%.
Key information
29.2%
Earnings growth rate
28.7%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | -13.1% |
| Return on equity | 44.0% |
| Net Margin | 116.8% |
| Next Earnings Update | 14 Feb 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Fortis Malar Hospitals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 412 | 482 | 6 | 0 |
| 31 Mar 24 | 590 | 453 | 6 | 0 |
| 31 Dec 23 | 741 | -157 | 10 | 0 |
| 30 Sep 23 | 785 | -129 | 10 | 0 |
| 30 Jun 23 | 836 | -154 | 10 | 0 |
| 31 Mar 23 | 860 | -155 | 10 | 0 |
| 31 Dec 22 | 879 | -89 | 11 | 0 |
| 30 Sep 22 | 865 | -105 | 11 | 0 |
| 30 Jun 22 | 831 | -99 | 11 | 0 |
| 31 Mar 22 | 862 | -83 | 11 | 0 |
| 31 Dec 21 | 834 | -91 | 10 | 0 |
| 30 Sep 21 | 858 | -73 | 10 | 0 |
| 30 Jun 21 | 830 | -63 | 10 | 0 |
| 31 Mar 21 | 692 | -79 | 10 | 0 |
| 31 Dec 20 | 716 | -90 | 58 | 0 |
| 30 Sep 20 | 759 | -101 | 58 | 0 |
| 30 Jun 20 | 894 | -105 | 58 | 0 |
| 31 Mar 20 | 1,119 | -89 | 58 | 0 |
| 31 Dec 19 | 1,267 | -53 | 41 | 0 |
| 30 Sep 19 | 1,365 | -22 | 82 | 0 |
| 30 Jun 19 | 1,411 | 9 | 82 | 0 |
| 31 Mar 19 | 1,446 | 21 | 82 | 0 |
| 31 Mar 18 | 1,492 | 33 | 91 | 0 |
| 31 Mar 17 | 1,406 | 31 | 64 | 0 |
| 31 Mar 16 | 1,296 | 64 | 43 | 0 |
| 31 Mar 15 | 1,179 | 79 | 45 | 0 |
| 31 Mar 14 | 1,084 | 88 | 86 | 0 |
Quality Earnings: 523696 has a large one-off gain of ₹591.2M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: 523696 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 523696 has become profitable over the past 5 years, growing earnings by 29.2% per year.
Accelerating Growth: 523696 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 523696 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (33.3%).
Return on Equity
High ROE: 523696's Return on Equity (44%) is considered outstanding.